Comparing the current results to its competitors, Bnb Plus reported Revenue increase in the 2 quarter 2026 by 4.14 % year on year. The revenue growth was below Bnb Plus 's competitors' average revenue growth of 7.04 %, achieved in the same quarter.
Bnb Plus Corp , slower than the average decrease reported by the company's competitors of -3.69 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -3.69 %
Bnb Plus 's Comment on Competition and Industry Peers
The company operates in the Therapeutic DNA Production Services segment, where it competes with MilliporeSigma, Precigen, Inc., Aldevron, LLC, Integrated DNA Technologies, Inc., 4basebio PLC, MaxCyte, Inc., Touchlight Genetics Ltd., Quantoom Bioscience, Syngoi Technologies, S.L.U., Novartis AG, OriGene Technologies, Inc., Blue Heron Biotech, LLC, Gene Art, GenScript Biotech Corporation, Elegen, Inc., ANSA Biotechnologies, and Merck & Co., Inc. In the DAT market, competitors include The Ether Machine, Sharplink Gaming Inc., Strategy, Inc., Solana Company, CEA Industries, Inc., Forward Industries, Inc., and Bitmine Immersion Technologies Inc. The company utilizes patents, trademarks, trade secrets, know-how, and ongoing innovation to sustain its competitive position in Therapeutic DNA Production Services.
Overall company revenue, grew less, than total company revenues, at 4.14 % and company approximately market share, declined to 0.02 %. << More on BNBX Market Share.
*Market share is calculated based on total revenue.
Myriad Genetics Inc's business model revolves around providing molecular diagnostic testing services and developing innovative precision medicine solutions that help identify and personalize treatment options for patients across various medical specialties.
Maxcyte Inc's business model revolves around providing cell engineering and flow electroporation technology to facilitate drug discovery, development, and manufacturing processes.
Ieh Corp operates as a technology consulting firm, offering a wide range of services to various industries. Their business model primarily focuses on providing customized solutions and technical expertise to help organizations streamline their operations and maximize efficiency. Through their consultative approach, Ieh Corp aims to establish long-term partnerships with clients, delivering innovative strategies and cutting-edge solutions tailored to their specific needs.
Generation Bio Co is a biotechnology company that focuses on developing innovative genetic medicines using its proprietary non-viral gene therapy platform. The company's business model involves leveraging its expertise in gene editing and delivery technologies to create transformative treatments for a wide range of genetic diseases. Generation Bio Co aims to collaborate with pharmaceutical partners to advance its pipeline and bring life-changing therapies to patients worldwide.
Sources:
Bnb Plus Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bnb Plus Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
